Close

BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $106 at Credit Suisse

June 6, 2022 6:05 AM EDT
Get Alerts BMRN Hot Sheet
Price: $87.34 -1.43%

Rating Summary:
    22 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Credit Suisse analyst Martin Auster raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $106.00 (from $105.00) while maintaining a Outperform rating.

You May Also Be Interested In





Related Categories

Analyst PT Change